Aurobindo Pharma gets final USFDA nod for cholesterol drug

"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fenofibrate Tablets, 48 mg and 145 mg," Aurobindo Pharma said
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news